Skip to main content

Aridis Pharmaceuticals, Inc.

ARDSDelisted Sep 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001614067

Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.

Q1 2026 vs. Q4 2025

How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of ARDS: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders01+1
Shares03.00K+3.00K
Value$0$1+$1

New holders (1)

Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to ARDS in Q1 2026
InstitutionSharesValue% of portfolio
Strengthening Families & Communities, LLC3,000$10.00%

Sold out (0)

Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

None.